Maynard Um
-
-
-
-
-
-
-
Sunshine Biopharma Announces Issuance of U.S. Patent 12,624,066 B2 Covering Novel Coronavirus Treatment Technology
-
-
-
-
-
-
-
Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering
-
-
-
-
-
-
-
Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline
-
-
-
-
-
-
-
Sunshine Biopharma develops new coronavirus protease inhibitors
-
-
-
-
-
-
-
Sunshine Biopharma Reports 2025 First Quarter Results, Revenues Up 18% Over Same Period Last Year
-
-
-
-
-
-
-
Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules
-
-
-
-
-
-
-
Sunshine Biopharma Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian $200 Million Market
-
419,878 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

